Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2018 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Host Fourth Quarter and Full Year 2017 Financial Results

RUTHERFORD, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
February 05, 2018 08:12 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Chief Executive Officer Steps Down

• Board Appoints COO, Jay Roberts, Interim Chief Executive Officer RUTHERFORD, N.J., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) an emerging leader in enabling precision...
January 17, 2018 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Expands Its Industry-Leading Immuno-Oncology Panel, Complete::IO™, to be the Most Comprehensive for Immune Profiling & Monitoring

- Simultaneously Assesses 27 Unique Immune Markers - Determines Optimal IO Therapies and Tracks Response and Resistance Mechanisms RUTHERFORD, N.J., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cancer...
December 28, 2017 07:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program

RUTHERFORD, N.J., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
December 19, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Receives New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific

The test serves as a companion diagnostic for three targeted therapies in non-small cell lung cancer (NSCLC) Global NSCLC diagnostic market projected to reach $3.65 billion by 2024 RUTHERFORD,...
December 11, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics advances understanding of immune response and measurement in lymphomas by combining PD-L1 expression analysis with RNA analysis

Study Presented at the 59th American Society of Hematology (ASH) Annual MeetingStudy focused on DLBCL (Diffuse Large B-Cell Lymphomas) RUTHERFORD, N.J., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Cancer...
December 08, 2017 08:58 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Prices $7 Million Registered Direct Offering

RUTHERFORD, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
November 30, 2017 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Participate in Upcoming Investor Conferences

RUTHERFORD, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
November 29, 2017 08:02 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Initiates Partnership to Reduce Alarmingly Increasing Cancer Mortality Rates in India

Collaboration with India’s premier professional oncology organization, the Indian Cooperative Oncology Network (ICON)Goal to bring CGI’s global expertise in clinical diagnostic assay development and...
November 29, 2017 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics and Indian Cooperative Oncology Network (ICON) Collaborate to Reduce Alarmingly Increasing Cancer Mortality Rates

Goal to bring CGI’s global expertise in clinical diagnostic assay development and as a drug development partner to optimize clinical outcomes for cancer patients; Aim to develop educational and...